v3.21.2
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Operating expenses:    
Research and development $ 18,705 $ 16,922
General and administrative 11,181 9,664
Total operating expenses 29,886 26,586
Other expense, net 626 74
Loss before (benefit) provision for income taxes (30,512) (26,660)
(Benefit) provision for income taxes (41) 48
Net loss $ (30,471) $ (26,708)
Net loss per common share - basic (in dollars per share) $ (0.31) $ (0.38)
Net loss per common share - diluted (in dollars per share) $ (0.31) $ (0.38)
Weighted-average common shares outstanding – basic (in shares) 97,976,982 70,818,867
Weighted-average common shares outstanding – diluted (in shares) 97,976,982 70,818,867

Source